40,000 people urged to sign-up to the largest study of depression and anxiety

Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London and the NIHR BioResource are calling for 40,000 people with depression or anxiety to join the online Genetic Links to Anxiety and Depression (GLAD) Study, funded by the NIHR.

By recruiting at least 40,000 people in England who have experienced either depression or anxiety at some point in their life, the Genetic Links to Anxiety and Depression (GLAD) Study will make important strides towards better understanding of these disorders and improving the lives of future patients. GLAD will provide a ‘pool’ of potential participants for future studies on the genetic aspects of these two conditions and reduce the time-consuming process of recruiting patients for research.

The study is led by  Dr Gerome Breen, Reader of Neuropsychiatric & Translational Genetics, NIHR Maudsley Biomedical Research Centre, IoPPN, King’s College London and he comments: “It’s a really exciting time to become involved in mental health research, particularly genetic research which has made incredible strides in recent years – we have so far identified 66 genetic links for depression and anxiety. By recruiting 40,000 volunteers willing to be re-contacted for research, the GLAD Study will take us further than ever before. It will allow researchers to solve the big unanswered questions, address how genes and environment act together and help develop new treatment options.”

The GLAD Study, funded by the National Institute for Health Research (NIHR) as a collaboration between the NIHR BioResource and King’s College London, has been designed to be particularly accessible, with a view to motivating more people to take part in mental health research.

Dr Sophie Dix, Director of Research at the charity MQ, which advocates for more research into mental health conditions, is supporting the GLAD Study. She comments: “Only through further research into the root causes of anxiety and depression can we hope to achieve the same breakthroughs that have been seen with other physical conditions. Our dream is a world where people can achieve full control of their mental health conditions, and where treatments are personalised to work for them. We encourage anyone living with depression or anxiety who shares this vision to enrol.”

Study co-lead, and anxiety expert, Professor Thalia Eley, Professor of Developmental Behavioural Genetics, NIHR Maudsley Biomedical Research Centre, IoPPN, King’s College London comments: “The GLAD Study is straightforward. We’re asking those who have experienced clinical anxiety or depression to complete a short survey and provide a DNA sample (from saliva). We want to hear from all different backgrounds, cultures, ethnic groups and genders, and we are especially keen to hear from young adults. By including people from all parts of the population what we learn will be relevant for everyone. This is a unique opportunity to participate in pioneering medical science – we hope the public back the study and we can reach our target of 40,000 people.”

The GLAD study is open to anyone in England, aged 16 or over, who has experienced clinical anxiety and/or depression. Taking part involves just two simple steps:

  1. Register at GLADStudy.org.uk and complete a 30 minute online questionnaire
  2. Complete and return a DNA saliva sample test, which is sent with instructions and a free return envelope

Signing up to the GLAD Study will also involve allowing access to your NHS medical records, providing important clinical data to link with other information and give a full picture of each individual. This data will be held securely (in line with new data regulations) and will only be accessed by a limited number of approved researchers. People who take part will receive updates twice-a-year about the progress of the research and online access to information on upcoming studies, watch a short animation on the study online for more information.

Cambridge team on the air waves

The NIHR Cambridge BioResource team were invited to Cambridge 105 Radio for an interview with Phil Rowe. 

Kelly, Barbara and Neil took part in the interview where they explained how to sign up and as a volunteer, what it involves and the importance of research on the Cambridge Biomedical Campus.

You can hear the interview here

Short film shows what it’s like to take part in a study as a healthy volunteer

Have you thought about signing up to the NIHR BioResource as a healthy volunteer?

As far as clinical research is concerned, it could be one of the best things you ever do!

When volunteers take part in our studies, they help researchers to understand more about the role of specific genes involved in the development of disease. And that could help them to identify better treatments or cures for disease.

So what happens when you join us as a healthy volunteer?

You can find out more elsewhere on our website – and you could also watch below a short film of one of our healthy volunteers, Michael, as he talks openly about what was involved for him when he signed up.


NIHR IBD BioResource reaches milestone of 10,000 recruits

A platform for research into Crohn’s Disease and Ulcerative Colitis has now signed up 10,000 participants nationwide.

The National Institute for Health Research (NIHR) IBD BioResource was established in 2016 by the UK IBD Genetics Consortium and the NIHR BioResource, to build on knowledge from recent genetics advances and accelerate the development of new treatments in Crohn’s disease and Ulcerative Colitis. Participants who have signed up to the NIHR IBD BioResource can be accessed by any investigators in the UK with an ethically approved research project, hence dramatically speeding up such research projects.

Inflammatory Bowel Disease (IBD) is a term used to describe two conditions, Crohn’s disease and Ulcerative Colitis. These lifelong illnesses mostly affect young adults and flare at intervals, producing debilitating symptoms including cramping abdominal pains, anemia, weight loss and diarrhoea. They require on-going drug therapy, and many patients also require major surgery. The exact causes of Crohn’s disease and Ulcerative Colitis are unclear, but the last 10 years has seen major progress in understanding the genetic contribution to these conditions.

NIHR IBD BioResource team

In the UK, more than 300,000 people are affected by Crohn’s disease or Ulcerative Colitis, and despite major advances in characterising the genetic and some of the environmental factors that predispose, much work remains to be done to fully understand IBD and develop better treatments.

Since its launch two years ago, the NIHR IBD BioResource has been rolled out to recruit in 62 hospital sites across the country. Earlier this week it hit the major milestone of 10,000 participants.

Dr Miles Parkes, a consultant gastroenterologist at Cambridge University Hospital and lead for NIHR IBD BioResource, said: “Getting to the 10,000 recruitment mark is a fantastic achievement and I am very grateful to all who have helped to make this possible.

“The IBD BioResource is a nationwide effort, recruiting people who have Crohn’s disease or Ulcerative Colitis specifically so that they can help researchers to better understand the causes of IBD and develop better treatments.”

People who sign up to the NIHR IBD BioResource provide a blood sample and complete a short health questionnaire. They will be contacted regarding future IBD research projects for which they meet inclusion criteria and given further information. They then decide study by study if they would like to participate or not. Participation could be to completing an online survey, provide a fresh blood sample or even participating in a trial of a new treatment.

Researchers from Cambridge, Edinburgh, London, Manchester and Oxford have already used the service to expedite their IBD research.

Dr Parkes added: “Since its launch we have been delighted by the level of enthusiasm shown by recruitment sites and patients alike, and particularly by the scale of interest from scientific community to use the NIHR IBD Bioresource. We are grateful for the continued support of our funding partners, clinicians and patients, without whom the success of the NIHR IBD BioResource would not be possible.

“Importantly our on-going large-scale recruitment of patients will allow us to fulfill our mission – to facilitate outstanding IBD research in the UK.” 

Helen Terry, Director of Research at Crohn’s and Colitis UK, said: “We are delighted to support this interactive BioResource which offers hope to thousands of patients suffering from Crohn’s Disease and Ulcerative Colitis (IBD).

“The 10,000 patients who have signed up are helping investigators to better understand and improve treatments for these debilitating, life-long illnesses. Access to this growing resource will enable researchers to translate the significant progress made in genetic research over the past few years into clinical benefit to improve the lives of people living with IBD and will open new doors to new discoveries.”

The NIHR IBD BioResource aims to open more sites across the country, with plans already for an extra 20 recruitment sites to be set-up by the autumn, with the long-term goal to achieve 25,000 participants.

For more information on the NIHR IBD BioResource, a website is available and explains how people with Crohn’s disease or Ulcerative Colitis can sign up, and how clinicians and investigators can get involved and access the NIHR IBD BioResource 

Cambridge Bioresource Newsletter – Issue: 8

Cambridge BioResource volunteers — like yourselves! — are currently supporting Prof Willem Ouwehand’s research team with a study looking at levels of different components of blood, particularly blood platelets. The aim of the study is to determine the link between differences in the DNA code and the volume, number and function of blood platelets…

Click here to read more in our Newsletter – Issue: 8


National BioResource Newsletter – Issue: 1

The NIHR BioResource is a federation of centres: London (at Guy’s and St Thomas’, South London and Maudsley, University College London), Leicester and Newcastle with their National Coordinating Centre (NCC) Headquarters based in Cambridge, and it is continuing to expand…

Click here to read more in our Newsletter – Issue: 1